This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are
presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.
"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.
Num | microRNA | Gene | miRNA log2FC | miRNA pvalue | Gene log2FC | Gene pvalue | Interaction | Correlation beta | Correlation P-value | PMID | Reported in cancer studies |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | hsa-let-7a-3p | ABCA1 | 1.42 | 0 | -0.71 | 0.00276 | mirMAP; miRNATAP | -0.28 | 0 | NA | |
2 | hsa-let-7a-3p | ABCC4 | 1.42 | 0 | -1.54 | 1.0E-5 | mirMAP | -0.19 | 0.01906 | NA | |
3 | hsa-let-7a-3p | ABCC9 | 1.42 | 0 | -2.76 | 0 | mirMAP | -0.65 | 0 | NA | |
4 | hsa-let-7a-3p | ABCD2 | 1.42 | 0 | -3.08 | 0 | mirMAP | -0.67 | 0 | NA | |
5 | hsa-let-7a-3p | ABCD3 | 1.42 | 0 | 0.14 | 0.52609 | MirTarget | -0.12 | 0.02959 | NA | |
6 | hsa-let-7a-3p | ABI3BP | 1.42 | 0 | -4.28 | 0 | miRNATAP | -0.98 | 0 | NA | |
7 | hsa-let-7a-3p | ABLIM1 | 1.42 | 0 | -1.72 | 0 | mirMAP | -0.15 | 0.02468 | NA | |
8 | hsa-let-7a-3p | ADAMTS5 | 1.42 | 0 | -2.16 | 0 | mirMAP | -0.34 | 1.0E-5 | NA | |
9 | hsa-let-7a-3p | ADAMTSL3 | 1.42 | 0 | -5.11 | 0 | MirTarget | -1.04 | 0 | NA | |
10 | hsa-let-7a-3p | ADCYAP1 | 1.42 | 0 | -3.51 | 0 | miRNATAP | -0.66 | 0 | NA | |
11 | hsa-let-7a-3p | ADD3 | 1.42 | 0 | -0.66 | 0.00185 | mirMAP; miRNATAP | -0.14 | 0.00449 | NA | |
12 | hsa-let-7a-3p | AFF2 | 1.42 | 0 | -1.73 | 0.00201 | mirMAP | -0.29 | 0.02983 | NA | |
13 | hsa-let-7a-3p | AFF3 | 1.42 | 0 | -5 | 0 | MirTarget | -1.07 | 0 | NA | |
14 | hsa-let-7a-3p | AKAP11 | 1.42 | 0 | -0.8 | 0 | mirMAP | -0.16 | 4.0E-5 | NA | |
15 | hsa-let-7a-3p | AKAP12 | 1.42 | 0 | -2.95 | 0 | miRNATAP | -0.59 | 0 | NA | |
16 | hsa-let-7a-3p | AKTIP | 1.42 | 0 | -0.35 | 0.01135 | MirTarget | -0.14 | 3.0E-5 | NA | |
17 | hsa-let-7a-3p | ALDH1L2 | 1.42 | 0 | -1.12 | 0.02448 | MirTarget | -0.24 | 0.04301 | NA | |
18 | hsa-let-7a-3p | AMN1 | 1.42 | 0 | -0.48 | 0.00493 | mirMAP | -0.12 | 0.00228 | NA | |
19 | hsa-let-7a-3p | AMOT | 1.42 | 0 | -1.51 | 0.00385 | mirMAP | -0.61 | 0 | NA | |
20 | hsa-let-7a-3p | AMOTL1 | 1.42 | 0 | -1.62 | 0 | mirMAP | -0.29 | 3.0E-5 | NA | |
21 | hsa-let-7a-3p | AMOTL2 | 1.42 | 0 | -1.01 | 0.00015 | miRNATAP | -0.19 | 0.00261 | NA | |
22 | hsa-let-7a-3p | ANKS1B | 1.42 | 0 | -3.65 | 0 | miRNATAP | -0.78 | 0 | NA | |
23 | hsa-let-7a-3p | ANO5 | 1.42 | 0 | -3.19 | 0 | mirMAP | -0.88 | 0 | NA | |
24 | hsa-let-7a-3p | ANTXR1 | 1.42 | 0 | -0.71 | 0.0159 | mirMAP; miRNATAP | -0.29 | 5.0E-5 | NA | |
25 | hsa-let-7a-3p | ARHGAP20 | 1.42 | 0 | -3.52 | 0 | MirTarget; miRNATAP | -0.72 | 0 | NA | |
26 | hsa-let-7a-3p | ARHGAP28 | 1.42 | 0 | -1.54 | 0.00053 | mirMAP | -0.4 | 0.00021 | NA | |
27 | hsa-let-7a-3p | ARHGAP29 | 1.42 | 0 | -0.34 | 0.31665 | mirMAP | -0.24 | 0.00278 | NA | |
28 | hsa-let-7a-3p | ARHGEF3 | 1.42 | 0 | -0.76 | 0 | MirTarget | -0.16 | 4.0E-5 | NA | |
29 | hsa-let-7a-3p | ARID4A | 1.42 | 0 | -0.76 | 0 | MirTarget; miRNATAP | -0.12 | 0.00103 | NA | |
30 | hsa-let-7a-3p | ARID5B | 1.42 | 0 | -1.57 | 0 | miRNATAP | -0.33 | 0 | NA | |
31 | hsa-let-7a-3p | ARSB | 1.42 | 0 | -0.58 | 0.00052 | mirMAP | -0.14 | 0.00029 | NA | |
32 | hsa-let-7a-3p | ART4 | 1.42 | 0 | -1.65 | 0.00419 | mirMAP | -0.63 | 1.0E-5 | NA | |
33 | hsa-let-7a-3p | ASAH1 | 1.42 | 0 | -0.59 | 0.00556 | MirTarget | -0.19 | 0.00013 | NA | |
34 | hsa-let-7a-3p | ASTN2 | 1.42 | 0 | -0.88 | 0.05369 | mirMAP | -0.38 | 0.00047 | NA | |
35 | hsa-let-7a-3p | ATE1 | 1.42 | 0 | -1.09 | 3.0E-5 | mirMAP | -0.16 | 0.01164 | NA | |
36 | hsa-let-7a-3p | AXIN2 | 1.42 | 0 | -1.7 | 6.0E-5 | miRNATAP | -0.58 | 0 | NA | |
37 | hsa-let-7a-3p | B3GAT2 | 1.42 | 0 | -1.18 | 0.00022 | mirMAP | -0.21 | 0.00552 | NA | |
38 | hsa-let-7a-3p | BCAS1 | 1.42 | 0 | -0.72 | 0.38851 | mirMAP | -0.46 | 0.02063 | NA | |
39 | hsa-let-7a-3p | BCL6 | 1.42 | 0 | -0.56 | 0.00743 | miRNATAP | -0.21 | 2.0E-5 | NA | |
40 | hsa-let-7a-3p | BEND4 | 1.42 | 0 | -1.97 | 7.0E-5 | mirMAP | -0.37 | 0.00181 | NA | |
41 | hsa-let-7a-3p | BEND6 | 1.42 | 0 | -0.8 | 0.03128 | mirMAP | -0.19 | 0.03467 | NA | |
42 | hsa-let-7a-3p | BEND7 | 1.42 | 0 | -0.64 | 0.19325 | mirMAP | -0.32 | 0.00616 | NA | |
43 | hsa-let-7a-3p | BMP3 | 1.42 | 0 | -0.54 | 0.56709 | MirTarget; mirMAP | -0.47 | 0.03703 | NA | |
44 | hsa-let-7a-3p | BMPR2 | 1.42 | 0 | -0.59 | 4.0E-5 | MirTarget; miRNATAP | -0.15 | 1.0E-5 | NA | |
45 | hsa-let-7a-3p | BNC2 | 1.42 | 0 | -2.95 | 0 | mirMAP | -0.64 | 0 | NA | |
46 | hsa-let-7a-3p | BST1 | 1.42 | 0 | -1.14 | 0.00705 | MirTarget | -0.26 | 0.01072 | NA | |
47 | hsa-let-7a-3p | BTNL9 | 1.42 | 0 | -2.01 | 9.0E-5 | MirTarget | -0.59 | 0 | NA | |
48 | hsa-let-7a-3p | BVES | 1.42 | 0 | -2.76 | 0 | mirMAP | -0.4 | 0.00049 | NA | |
49 | hsa-let-7a-3p | C8orf46 | 1.42 | 0 | -1.63 | 0.00027 | mirMAP | -0.36 | 0.00098 | NA | |
50 | hsa-let-7a-3p | CACNA1C | 1.42 | 0 | -2.53 | 0 | MirTarget | -0.85 | 0 | NA | |
51 | hsa-let-7a-3p | CACNA2D1 | 1.42 | 0 | -3.32 | 0 | mirMAP | -0.5 | 0.00221 | NA | |
52 | hsa-let-7a-3p | CACNB2 | 1.42 | 0 | -2.97 | 0 | MirTarget; mirMAP | -0.93 | 0 | NA | |
53 | hsa-let-7a-3p | CACNG4 | 1.42 | 0 | 1.13 | 0.16231 | MirTarget | -0.54 | 0.00571 | NA | |
54 | hsa-let-7a-3p | CASD1 | 1.42 | 0 | -0.65 | 0.0001 | MirTarget; miRNATAP | -0.17 | 1.0E-5 | NA | |
55 | hsa-let-7a-3p | CCDC141 | 1.42 | 0 | -2.94 | 0 | mirMAP | -0.48 | 0 | NA | |
56 | hsa-let-7a-3p | CCDC50 | 1.42 | 0 | -0.78 | 0 | miRNATAP | -0.11 | 0.0012 | NA | |
57 | hsa-let-7a-3p | CCND2 | 1.42 | 0 | -2.43 | 0 | mirMAP | -0.44 | 0 | 20418948 | MicroRNA let 7a inhibits proliferation of human prostate cancer cells in vitro and in vivo by targeting E2F2 and CCND2 |
58 | hsa-let-7a-3p | CCPG1 | 1.42 | 0 | -1 | 0 | mirMAP | -0.15 | 0.00139 | NA | |
59 | hsa-let-7a-3p | CD302 | 1.42 | 0 | -1.68 | 0 | mirMAP | -0.23 | 1.0E-5 | NA | |
60 | hsa-let-7a-3p | CDC14A | 1.42 | 0 | -0.5 | 0.01927 | mirMAP | -0.11 | 0.03893 | NA | |
61 | hsa-let-7a-3p | CDC14B | 1.42 | 0 | -0.81 | 2.0E-5 | miRNATAP | -0.1 | 0.02522 | NA | |
62 | hsa-let-7a-3p | CDC42EP3 | 1.42 | 0 | -1.35 | 0 | MirTarget; mirMAP | -0.36 | 0 | NA | |
63 | hsa-let-7a-3p | CDHR3 | 1.42 | 0 | -1.17 | 0.00028 | mirMAP | -0.16 | 0.04012 | NA | |
64 | hsa-let-7a-3p | CDK20 | 1.42 | 0 | -0.6 | 0.0413 | MirTarget | -0.3 | 2.0E-5 | NA | |
65 | hsa-let-7a-3p | CELF2 | 1.42 | 0 | -3.05 | 0 | miRNATAP | -0.62 | 0 | NA | |
66 | hsa-let-7a-3p | CFL2 | 1.42 | 0 | -2.62 | 0 | mirMAP | -0.45 | 0 | NA | |
67 | hsa-let-7a-3p | CHL1 | 1.42 | 0 | -2.42 | 0.00043 | MirTarget; miRNATAP | -0.56 | 0.0008 | NA | |
68 | hsa-let-7a-3p | CLIC4 | 1.42 | 0 | -1.72 | 0 | MirTarget | -0.3 | 0.00011 | NA | |
69 | hsa-let-7a-3p | CLIP1 | 1.42 | 0 | -0.85 | 0 | miRNATAP | -0.1 | 0.02017 | NA | |
70 | hsa-let-7a-3p | CNKSR2 | 1.42 | 0 | -2.85 | 0 | MirTarget; mirMAP; miRNATAP | -0.55 | 0 | NA | |
71 | hsa-let-7a-3p | CNR1 | 1.42 | 0 | -2.44 | 4.0E-5 | mirMAP | -0.44 | 0.00223 | NA | |
72 | hsa-let-7a-3p | CNTN1 | 1.42 | 0 | -4.98 | 0 | MirTarget; miRNATAP | -0.76 | 0.00012 | NA | |
73 | hsa-let-7a-3p | COL13A1 | 1.42 | 0 | -1.01 | 0.009 | miRNATAP | -0.22 | 0.02042 | NA | |
74 | hsa-let-7a-3p | COL15A1 | 1.42 | 0 | -0.94 | 0.00988 | MirTarget | -0.39 | 1.0E-5 | NA | |
75 | hsa-let-7a-3p | COL1A2 | 1.42 | 0 | -0.91 | 0.05362 | MirTarget | -0.34 | 0.00237 | NA | |
76 | hsa-let-7a-3p | COL4A1 | 1.42 | 0 | 0.15 | 0.58169 | miRNATAP | -0.21 | 0.00159 | NA | |
77 | hsa-let-7a-3p | COL4A4 | 1.42 | 0 | -2.67 | 0 | mirMAP | -0.73 | 0 | NA | |
78 | hsa-let-7a-3p | CPEB2 | 1.42 | 0 | -1.81 | 0 | mirMAP; miRNATAP | -0.13 | 0.02325 | NA | |
79 | hsa-let-7a-3p | CPEB3 | 1.42 | 0 | -1.3 | 0 | MirTarget; miRNATAP | -0.2 | 1.0E-5 | NA | |
80 | hsa-let-7a-3p | CPEB4 | 1.42 | 0 | -1.56 | 0 | mirMAP; miRNATAP | -0.29 | 0 | NA | |
81 | hsa-let-7a-3p | CREBL2 | 1.42 | 0 | -0.7 | 0 | mirMAP | -0.12 | 0.00076 | NA | |
82 | hsa-let-7a-3p | CRIM1 | 1.42 | 0 | -0.45 | 0.0534 | MirTarget | -0.16 | 0.00449 | NA | |
83 | hsa-let-7a-3p | CRTC3 | 1.42 | 0 | -0.76 | 0 | MirTarget | -0.22 | 0 | NA | |
84 | hsa-let-7a-3p | CSTF2T | 1.42 | 0 | -0.61 | 0.00221 | MirTarget | -0.12 | 0.01691 | NA | |
85 | hsa-let-7a-3p | CUX2 | 1.42 | 0 | -1.95 | 2.0E-5 | MirTarget; miRNATAP | -0.36 | 0.00139 | NA | |
86 | hsa-let-7a-3p | CX3CR1 | 1.42 | 0 | -1.46 | 8.0E-5 | MirTarget | -0.38 | 2.0E-5 | NA | |
87 | hsa-let-7a-3p | CYBRD1 | 1.42 | 0 | -2.55 | 0 | mirMAP | -0.38 | 4.0E-5 | NA | |
88 | hsa-let-7a-3p | CYP1B1 | 1.42 | 0 | -2.82 | 0 | mirMAP | -0.47 | 0.00089 | NA | |
89 | hsa-let-7a-3p | DAB1 | 1.42 | 0 | -1.92 | 0.01373 | mirMAP | -0.96 | 0 | NA | |
90 | hsa-let-7a-3p | DACH1 | 1.42 | 0 | -2.45 | 0 | MirTarget | -0.24 | 0.02345 | NA | |
91 | hsa-let-7a-3p | DACH2 | 1.42 | 0 | -0.77 | 0.28047 | mirMAP | -0.38 | 0.02762 | NA | |
92 | hsa-let-7a-3p | DACT1 | 1.42 | 0 | -1.78 | 2.0E-5 | MirTarget | -0.5 | 0 | NA | |
93 | hsa-let-7a-3p | DENND4C | 1.42 | 0 | -0.64 | 0.00049 | MirTarget | -0.16 | 0.00038 | NA | |
94 | hsa-let-7a-3p | DLL4 | 1.42 | 0 | -0.14 | 0.54558 | miRNATAP | -0.2 | 0.00031 | NA | |
95 | hsa-let-7a-3p | DMXL1 | 1.42 | 0 | -0.95 | 0 | mirMAP | -0.11 | 0.0042 | NA | |
96 | hsa-let-7a-3p | DNAJB5 | 1.42 | 0 | -2.65 | 0 | miRNATAP | -0.37 | 1.0E-5 | NA | |
97 | hsa-let-7a-3p | DNALI1 | 1.42 | 0 | -2.11 | 4.0E-5 | MirTarget; miRNATAP | -0.6 | 0 | NA | |
98 | hsa-let-7a-3p | DNM3 | 1.42 | 0 | -1.22 | 4.0E-5 | MirTarget | -0.18 | 0.0114 | NA | |
99 | hsa-let-7a-3p | DOCK1 | 1.42 | 0 | -0.68 | 0.00032 | MirTarget; miRNATAP | -0.11 | 0.01618 | NA | |
100 | hsa-let-7a-3p | DOCK11 | 1.42 | 0 | -1.8 | 0 | MirTarget; miRNATAP | -0.44 | 0 | NA | |
101 | hsa-let-7a-3p | DOK6 | 1.42 | 0 | -3.8 | 0 | mirMAP | -0.92 | 0 | NA | |
102 | hsa-let-7a-3p | DUSP19 | 1.42 | 0 | -0.99 | 1.0E-5 | mirMAP | -0.23 | 1.0E-5 | NA | |
103 | hsa-let-7a-3p | EBF1 | 1.42 | 0 | -2.89 | 0 | mirMAP; miRNATAP | -0.64 | 0 | NA | |
104 | hsa-let-7a-3p | EBF3 | 1.42 | 0 | -2.22 | 0 | MirTarget; miRNATAP | -0.43 | 0 | NA | |
105 | hsa-let-7a-3p | EDIL3 | 1.42 | 0 | -1.4 | 0.00541 | MirTarget | -0.34 | 0.00495 | NA | |
106 | hsa-let-7a-3p | EGFL6 | 1.42 | 0 | -0.53 | 0.10258 | MirTarget | -0.17 | 0.02941 | NA | |
107 | hsa-let-7a-3p | EIF4E3 | 1.42 | 0 | -1.31 | 0 | mirMAP | -0.25 | 1.0E-5 | NA | |
108 | hsa-let-7a-3p | ELOVL2 | 1.42 | 0 | -1.4 | 0.00118 | miRNATAP | -0.37 | 0.00035 | NA | |
109 | hsa-let-7a-3p | EML1 | 1.42 | 0 | -2.07 | 0 | MirTarget | -0.59 | 0 | NA | |
110 | hsa-let-7a-3p | ENPP1 | 1.42 | 0 | -2.1 | 0 | mirMAP | -0.47 | 2.0E-5 | NA | |
111 | hsa-let-7a-3p | ENPP4 | 1.42 | 0 | -0.94 | 0.00706 | mirMAP | -0.49 | 0 | NA | |
112 | hsa-let-7a-3p | ENTPD1 | 1.42 | 0 | -1.12 | 0 | mirMAP | -0.34 | 0 | NA | |
113 | hsa-let-7a-3p | EPB41L1 | 1.42 | 0 | -0.41 | 0.15237 | miRNATAP | -0.22 | 0.00128 | NA | |
114 | hsa-let-7a-3p | EPHA3 | 1.42 | 0 | -3.18 | 0 | mirMAP; miRNATAP | -0.55 | 0 | NA | |
115 | hsa-let-7a-3p | EPHA7 | 1.42 | 0 | -4.2 | 0 | mirMAP; miRNATAP | -0.97 | 0 | NA | |
116 | hsa-let-7a-3p | ESR1 | 1.42 | 0 | -2.87 | 0 | mirMAP | -0.38 | 0.00081 | 20535543; 21826373 | Let 7 family miRNAs regulate estrogen receptor alpha signaling in estrogen receptor positive breast cancer; Next we performed bioinformatics analysis and found that let-7 miRNA sequences match sequence in the 3'-UTR of estrogen receptor alpha ER-α suggesting ER-α may be a target of let-7 which was further confirmed by a number of experimental assays including luciferase assay protein expression and mRNA expression;let 7 microRNAs induce tamoxifen sensitivity by downregulation of estrogen receptor α signaling in breast cancer |
117 | hsa-let-7a-3p | EVI2A | 1.42 | 0 | -1.18 | 0.00499 | MirTarget | -0.27 | 0.00664 | NA | |
118 | hsa-let-7a-3p | FAM102B | 1.42 | 0 | -1.36 | 0 | mirMAP | -0.14 | 0.01409 | NA | |
119 | hsa-let-7a-3p | FAM117A | 1.42 | 0 | -1.06 | 0 | miRNATAP | -0.25 | 0 | NA | |
120 | hsa-let-7a-3p | FAM160B1 | 1.42 | 0 | -0.46 | 0.00084 | mirMAP | -0.18 | 0 | NA | |
121 | hsa-let-7a-3p | FAM171A1 | 1.42 | 0 | -1.6 | 4.0E-5 | miRNATAP | -0.35 | 0.00016 | NA | |
122 | hsa-let-7a-3p | FAM19A2 | 1.42 | 0 | -2.67 | 0 | miRNATAP | -0.29 | 0.00261 | NA | |
123 | hsa-let-7a-3p | FAM19A5 | 1.42 | 0 | -0.93 | 0.03784 | MirTarget; miRNATAP | -0.51 | 0 | NA | |
124 | hsa-let-7a-3p | FAM26E | 1.42 | 0 | -1.51 | 4.0E-5 | mirMAP | -0.38 | 2.0E-5 | NA | |
125 | hsa-let-7a-3p | FAM46A | 1.42 | 0 | -1.54 | 0 | mirMAP | -0.13 | 0.02272 | NA | |
126 | hsa-let-7a-3p | FAM47E | 1.42 | 0 | -0.45 | 0.25689 | MirTarget | -0.37 | 0.0001 | NA | |
127 | hsa-let-7a-3p | FAM63B | 1.42 | 0 | -0.55 | 0.03992 | mirMAP | -0.14 | 0.02521 | NA | |
128 | hsa-let-7a-3p | FAT3 | 1.42 | 0 | -2.79 | 0 | miRNATAP | -0.84 | 0 | NA | |
129 | hsa-let-7a-3p | FBN1 | 1.42 | 0 | -1.82 | 5.0E-5 | mirMAP | -0.53 | 0 | NA | |
130 | hsa-let-7a-3p | FBXO32 | 1.42 | 0 | -0.93 | 0.00122 | mirMAP | -0.38 | 0 | NA | |
131 | hsa-let-7a-3p | FGF13 | 1.42 | 0 | -2.8 | 0 | MirTarget; miRNATAP | -0.48 | 0 | NA | |
132 | hsa-let-7a-3p | FGF2 | 1.42 | 0 | -3.46 | 0 | mirMAP | -0.57 | 0 | NA | |
133 | hsa-let-7a-3p | FGF7 | 1.42 | 0 | -3.51 | 0 | MirTarget; miRNATAP | -0.87 | 0 | NA | |
134 | hsa-let-7a-3p | FGFR2 | 1.42 | 0 | -1.11 | 0.01288 | miRNATAP | -0.4 | 0.00015 | NA | |
135 | hsa-let-7a-3p | FIGN | 1.42 | 0 | -0.34 | 0.46881 | mirMAP | -0.25 | 0.02499 | NA | |
136 | hsa-let-7a-3p | FKBP7 | 1.42 | 0 | -0.88 | 5.0E-5 | mirMAP | -0.27 | 0 | NA | |
137 | hsa-let-7a-3p | FNIP2 | 1.42 | 0 | -0.76 | 0.01045 | mirMAP | -0.18 | 0.0132 | NA | |
138 | hsa-let-7a-3p | FOXO1 | 1.42 | 0 | -1.06 | 0 | MirTarget; miRNATAP | -0.14 | 0.00213 | NA | |
139 | hsa-let-7a-3p | FOXP1 | 1.42 | 0 | -0.87 | 0 | miRNATAP | -0.18 | 6.0E-5 | NA | |
140 | hsa-let-7a-3p | FOXP2 | 1.42 | 0 | -3.99 | 0 | MirTarget; mirMAP | -0.6 | 7.0E-5 | NA | |
141 | hsa-let-7a-3p | FREM2 | 1.42 | 0 | -0.14 | 0.88581 | MirTarget; mirMAP | -0.89 | 0.00016 | NA | |
142 | hsa-let-7a-3p | FRMD3 | 1.42 | 0 | -2.55 | 0 | mirMAP; miRNATAP | -0.48 | 0 | NA | |
143 | hsa-let-7a-3p | FRMD4A | 1.42 | 0 | -0.28 | 0.24286 | miRNATAP | -0.12 | 0.04101 | NA | |
144 | hsa-let-7a-3p | FSTL1 | 1.42 | 0 | -1.2 | 3.0E-5 | mirMAP | -0.32 | 0 | NA | |
145 | hsa-let-7a-3p | FYN | 1.42 | 0 | -1.47 | 0 | miRNATAP | -0.4 | 0 | NA | |
146 | hsa-let-7a-3p | FZD3 | 1.42 | 0 | -0.31 | 0.22562 | MirTarget; miRNATAP | -0.15 | 0.01617 | NA | |
147 | hsa-let-7a-3p | FZD4 | 1.42 | 0 | -0.83 | 0.00068 | mirMAP | -0.26 | 1.0E-5 | NA | |
148 | hsa-let-7a-3p | GAB1 | 1.42 | 0 | -0.89 | 0 | mirMAP | -0.18 | 3.0E-5 | NA | |
149 | hsa-let-7a-3p | GABRB3 | 1.42 | 0 | -1.66 | 0.03874 | miRNATAP | -0.49 | 0.0108 | NA | |
150 | hsa-let-7a-3p | GAS1 | 1.42 | 0 | -2.19 | 0.00038 | miRNATAP | -0.56 | 0.00014 | NA |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT | 96 | 1672 | 1.849e-18 | 8.605e-15 |
2 | REGULATION OF CELL DIFFERENTIATION | 86 | 1492 | 1.329e-16 | 2.989e-13 |
3 | REGULATION OF CELL DEVELOPMENT | 61 | 836 | 1.927e-16 | 2.989e-13 |
4 | NEUROGENESIS | 81 | 1402 | 1.078e-15 | 1.254e-12 |
5 | REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 54 | 750 | 2.132e-14 | 1.984e-11 |
6 | REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS | 63 | 1021 | 1.454e-13 | 1.127e-10 |
7 | REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 84 | 1656 | 4.365e-13 | 2.901e-10 |
8 | REGULATION OF NEURON DIFFERENTIATION | 42 | 554 | 3.903e-12 | 2.27e-09 |
9 | POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 73 | 1395 | 4.637e-12 | 2.397e-09 |
10 | POSITIVE REGULATION OF DEVELOPMENTAL PROCESS | 64 | 1142 | 6.51e-12 | 3.029e-09 |
11 | RESPONSE TO ENDOGENOUS STIMULUS | 74 | 1450 | 1.068e-11 | 4.519e-09 |
12 | NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS | 51 | 801 | 1.24e-11 | 4.807e-09 |
13 | CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND | 50 | 799 | 3.723e-11 | 1.333e-08 |
14 | REGULATION OF CELL PROJECTION ORGANIZATION | 40 | 558 | 7.229e-11 | 2.349e-08 |
15 | CELLULAR RESPONSE TO ENDOGENOUS STIMULUS | 57 | 1008 | 7.572e-11 | 2.349e-08 |
16 | POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS | 57 | 1036 | 2.156e-10 | 5.902e-08 |
17 | POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 57 | 1036 | 2.156e-10 | 5.902e-08 |
18 | REGULATION OF PHOSPHORUS METABOLIC PROCESS | 76 | 1618 | 2.713e-10 | 7.012e-08 |
19 | CELLULAR RESPONSE TO ORGANIC SUBSTANCE | 83 | 1848 | 3.117e-10 | 7.634e-08 |
20 | REGULATION OF CELLULAR COMPONENT MOVEMENT | 47 | 771 | 3.603e-10 | 8.382e-08 |
21 | BEHAVIOR | 37 | 516 | 3.835e-10 | 8.497e-08 |
22 | REGULATION OF PROTEIN MODIFICATION PROCESS | 78 | 1710 | 5.907e-10 | 1.249e-07 |
23 | NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 54 | 983 | 7.179e-10 | 1.369e-07 |
24 | CARDIOVASCULAR SYSTEM DEVELOPMENT | 47 | 788 | 7.355e-10 | 1.369e-07 |
25 | CIRCULATORY SYSTEM DEVELOPMENT | 47 | 788 | 7.355e-10 | 1.369e-07 |
26 | POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 59 | 1135 | 8.925e-10 | 1.597e-07 |
27 | MORPHOGENESIS OF A BRANCHING STRUCTURE | 20 | 167 | 9.466e-10 | 1.631e-07 |
28 | POSITIVE REGULATION OF CELL DIFFERENTIATION | 48 | 823 | 1.001e-09 | 1.664e-07 |
29 | TISSUE DEVELOPMENT | 71 | 1518 | 1.405e-09 | 2.254e-07 |
30 | POSITIVE REGULATION OF CELL DEVELOPMENT | 34 | 472 | 1.81e-09 | 2.808e-07 |
31 | ORGAN MORPHOGENESIS | 48 | 841 | 2.029e-09 | 3.045e-07 |
32 | TUBE DEVELOPMENT | 37 | 552 | 2.445e-09 | 3.556e-07 |
33 | SINGLE ORGANISM BEHAVIOR | 30 | 384 | 2.597e-09 | 3.662e-07 |
34 | NEGATIVE REGULATION OF CELL DIFFERENTIATION | 39 | 609 | 3.21e-09 | 4.393e-07 |
35 | CELL DEVELOPMENT | 67 | 1426 | 3.682e-09 | 4.894e-07 |
36 | REGULATION OF GTPASE ACTIVITY | 41 | 673 | 5.268e-09 | 6.808e-07 |
37 | RESPONSE TO OXYGEN CONTAINING COMPOUND | 65 | 1381 | 6.101e-09 | 7.673e-07 |
38 | LOCOMOTION | 56 | 1114 | 8.26e-09 | 1.011e-06 |
39 | POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS | 68 | 1492 | 9.42e-09 | 1.124e-06 |
40 | POSITIVE REGULATION OF MOLECULAR FUNCTION | 77 | 1791 | 1.077e-08 | 1.193e-06 |
41 | MOVEMENT OF CELL OR SUBCELLULAR COMPONENT | 61 | 1275 | 1.05e-08 | 1.193e-06 |
42 | REGULATION OF NEURON PROJECTION DEVELOPMENT | 30 | 408 | 1.053e-08 | 1.193e-06 |
43 | BLOOD VESSEL MORPHOGENESIS | 28 | 364 | 1.25e-08 | 1.353e-06 |
44 | POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 31 | 437 | 1.377e-08 | 1.456e-06 |
45 | INTRACELLULAR SIGNAL TRANSDUCTION | 70 | 1572 | 1.413e-08 | 1.461e-06 |
46 | VASCULATURE DEVELOPMENT | 32 | 469 | 2.013e-08 | 2.036e-06 |
47 | REGULATION OF CELLULAR COMPONENT BIOGENESIS | 43 | 767 | 2.499e-08 | 2.474e-06 |
48 | REGULATION OF MAPK CASCADE | 39 | 660 | 2.894e-08 | 2.805e-06 |
49 | ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY | 40 | 689 | 3.087e-08 | 2.932e-06 |
50 | CELLULAR RESPONSE TO NITROGEN COMPOUND | 33 | 505 | 3.394e-08 | 3.158e-06 |
51 | REGULATION OF SYSTEM PROCESS | 33 | 507 | 3.728e-08 | 3.402e-06 |
52 | REGULATION OF HYDROLASE ACTIVITY | 61 | 1327 | 4.492e-08 | 4.02e-06 |
53 | TUBE MORPHOGENESIS | 25 | 323 | 6.779e-08 | 5.951e-06 |
54 | CENTRAL NERVOUS SYSTEM DEVELOPMENT | 45 | 872 | 1.306e-07 | 1.126e-05 |
55 | NEURON DIFFERENTIATION | 45 | 874 | 1.394e-07 | 1.18e-05 |
56 | GROWTH | 28 | 410 | 1.549e-07 | 1.287e-05 |
57 | HEAD DEVELOPMENT | 39 | 709 | 1.892e-07 | 1.544e-05 |
58 | NEGATIVE REGULATION OF CELL COMMUNICATION | 55 | 1192 | 1.982e-07 | 1.59e-05 |
59 | POSITIVE REGULATION OF CATALYTIC ACTIVITY | 65 | 1518 | 2.117e-07 | 1.669e-05 |
60 | BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE | 15 | 131 | 2.19e-07 | 1.698e-05 |
61 | POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION | 11 | 67 | 2.342e-07 | 1.787e-05 |
62 | RESPONSE TO HORMONE | 45 | 893 | 2.559e-07 | 1.921e-05 |
63 | TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY | 31 | 498 | 2.615e-07 | 1.931e-05 |
64 | CELLULAR RESPONSE TO HORMONE STIMULUS | 33 | 552 | 2.695e-07 | 1.959e-05 |
65 | MODULATION OF SYNAPTIC TRANSMISSION | 23 | 301 | 2.867e-07 | 2.052e-05 |
66 | MUSCLE SYSTEM PROCESS | 22 | 282 | 3.653e-07 | 2.575e-05 |
67 | TISSUE MORPHOGENESIS | 32 | 533 | 3.74e-07 | 2.597e-05 |
68 | POSITIVE REGULATION OF NEURON DIFFERENTIATION | 23 | 306 | 3.838e-07 | 2.626e-05 |
69 | SKELETAL SYSTEM DEVELOPMENT | 29 | 455 | 3.948e-07 | 2.662e-05 |
70 | BIOLOGICAL ADHESION | 49 | 1032 | 4.269e-07 | 2.837e-05 |
71 | POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION | 13 | 103 | 4.545e-07 | 2.978e-05 |
72 | REGULATION OF OSSIFICATION | 17 | 178 | 4.824e-07 | 3.118e-05 |
73 | EPITHELIUM DEVELOPMENT | 46 | 945 | 4.97e-07 | 3.168e-05 |
74 | REGULATION OF CELL PROLIFERATION | 63 | 1496 | 5.948e-07 | 3.74e-05 |
75 | REGULATION OF TRANSPORT | 72 | 1804 | 6.358e-07 | 3.945e-05 |
76 | RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE | 6 | 16 | 7.574e-07 | 4.637e-05 |
77 | REGULATION OF CELL MORPHOGENESIS | 32 | 552 | 8.052e-07 | 4.866e-05 |
78 | SYNAPSE ORGANIZATION | 15 | 145 | 8.229e-07 | 4.909e-05 |
79 | REGULATION OF EPITHELIAL CELL MIGRATION | 16 | 166 | 9.254e-07 | 5.45e-05 |
80 | MORPHOGENESIS OF AN EPITHELIUM | 26 | 400 | 1.102e-06 | 6.408e-05 |
81 | POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION | 22 | 303 | 1.228e-06 | 7.055e-05 |
82 | POSITIVE REGULATION OF KINASE ACTIVITY | 29 | 482 | 1.276e-06 | 7.242e-05 |
83 | RESPONSE TO ORGANIC CYCLIC COMPOUND | 44 | 917 | 1.312e-06 | 7.353e-05 |
84 | REGULATION OF ENDOTHELIAL CELL MIGRATION | 13 | 114 | 1.476e-06 | 8.079e-05 |
85 | NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 38 | 740 | 1.471e-06 | 8.079e-05 |
86 | REGULATION OF CELL DEATH | 61 | 1472 | 1.561e-06 | 8.447e-05 |
87 | CELL PROJECTION ORGANIZATION | 43 | 902 | 2.061e-06 | 0.0001102 |
88 | POSITIVE REGULATION OF CELL PROLIFERATION | 40 | 814 | 2.291e-06 | 0.0001212 |
89 | POSITIVE REGULATION OF GENE EXPRESSION | 68 | 1733 | 2.486e-06 | 0.00013 |
90 | POSITIVE REGULATION OF LOCOMOTION | 26 | 420 | 2.714e-06 | 0.0001403 |
91 | REGULATION OF MAP KINASE ACTIVITY | 22 | 319 | 2.864e-06 | 0.0001464 |
92 | REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 69 | 1784 | 3.416e-06 | 0.0001728 |
93 | RESPONSE TO NITROGEN COMPOUND | 41 | 859 | 3.5e-06 | 0.0001751 |
94 | COGNITION | 19 | 251 | 3.567e-06 | 0.0001766 |
95 | REGULATION OF FAT CELL DIFFERENTIATION | 12 | 106 | 4.034e-06 | 0.0001976 |
96 | CELL MOTILITY | 40 | 835 | 4.243e-06 | 0.0002035 |
97 | LOCALIZATION OF CELL | 40 | 835 | 4.243e-06 | 0.0002035 |
98 | CELLULAR COMPONENT MORPHOGENESIS | 42 | 900 | 4.633e-06 | 0.00022 |
99 | MUSCLE CONTRACTION | 18 | 233 | 4.84e-06 | 0.0002275 |
100 | NEURON PROJECTION DEVELOPMENT | 30 | 545 | 5.049e-06 | 0.0002349 |
101 | REGULATION OF LIPID METABOLIC PROCESS | 20 | 282 | 5.328e-06 | 0.0002431 |
102 | NEGATIVE REGULATION OF RESPONSE TO STIMULUS | 56 | 1360 | 5.321e-06 | 0.0002431 |
103 | HEART MORPHOGENESIS | 17 | 212 | 5.392e-06 | 0.0002436 |
104 | POSITIVE REGULATION OF CELL COMMUNICATION | 61 | 1532 | 5.591e-06 | 0.0002501 |
105 | PROTEIN PHOSPHORYLATION | 43 | 944 | 6.497e-06 | 0.0002879 |
106 | REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 22 | 337 | 6.919e-06 | 0.0003037 |
107 | POSITIVE REGULATION OF MAPK CASCADE | 27 | 470 | 6.985e-06 | 0.0003038 |
108 | POSITIVE REGULATION OF RESPONSE TO STIMULUS | 72 | 1929 | 7.079e-06 | 0.000305 |
109 | REGULATION OF OSTEOBLAST DIFFERENTIATION | 12 | 112 | 7.184e-06 | 0.0003067 |
110 | REGULATION OF DEVELOPMENTAL GROWTH | 20 | 289 | 7.679e-06 | 0.0003248 |
111 | REGULATION OF ORGAN MORPHOGENESIS | 18 | 242 | 8.187e-06 | 0.0003432 |
112 | RESPIRATORY SYSTEM DEVELOPMENT | 16 | 197 | 8.645e-06 | 0.0003592 |
113 | POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 49 | 1152 | 9.261e-06 | 0.0003813 |
114 | BONE DEVELOPMENT | 14 | 156 | 1.015e-05 | 0.0004142 |
115 | REGULATION OF BLOOD CIRCULATION | 20 | 295 | 1.04e-05 | 0.0004208 |
116 | REGULATION OF KINASE ACTIVITY | 37 | 776 | 1.093e-05 | 0.0004383 |
117 | CELLULAR RESPONSE TO LIPID | 26 | 457 | 1.224e-05 | 0.0004712 |
118 | POSITIVE REGULATION OF HYDROLASE ACTIVITY | 41 | 905 | 1.224e-05 | 0.0004712 |
119 | CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 28 | 513 | 1.222e-05 | 0.0004712 |
120 | RHYTHMIC PROCESS | 20 | 298 | 1.206e-05 | 0.0004712 |
121 | REGULATION OF CELL ADHESION | 32 | 629 | 1.225e-05 | 0.0004712 |
122 | SECRETION BY CELL | 27 | 486 | 1.277e-05 | 0.0004792 |
123 | NEGATIVE REGULATION OF TRANSPORT | 26 | 458 | 1.271e-05 | 0.0004792 |
124 | UROGENITAL SYSTEM DEVELOPMENT | 20 | 299 | 1.267e-05 | 0.0004792 |
125 | REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC | 8 | 50 | 1.292e-05 | 0.0004809 |
126 | MUSCLE STRUCTURE DEVELOPMENT | 25 | 432 | 1.35e-05 | 0.0004984 |
127 | SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 22 | 352 | 1.371e-05 | 0.0005022 |
128 | EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS | 6 | 25 | 1.414e-05 | 0.000514 |
129 | MUSCLE ORGAN DEVELOPMENT | 19 | 277 | 1.465e-05 | 0.0005285 |
130 | ACTIVATION OF PROTEIN KINASE ACTIVITY | 19 | 279 | 1.621e-05 | 0.0005801 |
131 | NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 25 | 437 | 1.639e-05 | 0.0005804 |
132 | SENSORY ORGAN DEVELOPMENT | 27 | 493 | 1.646e-05 | 0.0005804 |
133 | HEART DEVELOPMENT | 26 | 466 | 1.716e-05 | 0.0006004 |
134 | RESPONSE TO LIPID | 40 | 888 | 1.789e-05 | 0.0006212 |
135 | POSITIVE REGULATION OF BIOSYNTHETIC PROCESS | 67 | 1805 | 1.852e-05 | 0.0006378 |
136 | REGULATION OF RESPONSE TO WOUNDING | 24 | 413 | 1.874e-05 | 0.0006378 |
137 | DEVELOPMENTAL GROWTH | 21 | 333 | 1.878e-05 | 0.0006378 |
138 | REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 26 | 470 | 1.988e-05 | 0.0006702 |
139 | NEGATIVE REGULATION OF GENE EXPRESSION | 58 | 1493 | 2.009e-05 | 0.0006726 |
140 | ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS | 42 | 957 | 2.029e-05 | 0.0006742 |
141 | MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL | 7 | 39 | 2.079e-05 | 0.0006811 |
142 | POSITIVE REGULATION OF TRANSFERASE ACTIVITY | 31 | 616 | 2.07e-05 | 0.0006811 |
143 | RESPONSE TO ALCOHOL | 22 | 362 | 2.111e-05 | 0.000687 |
144 | SECRETION | 30 | 588 | 2.178e-05 | 0.0006994 |
145 | REGULATION OF EPITHELIAL CELL PROLIFERATION | 19 | 285 | 2.179e-05 | 0.0006994 |
146 | HIPPO SIGNALING | 6 | 27 | 2.276e-05 | 0.0007206 |
147 | AXIS ELONGATION | 6 | 27 | 2.276e-05 | 0.0007206 |
148 | RESPONSE TO GROWTH FACTOR | 26 | 475 | 2.382e-05 | 0.0007488 |
149 | NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 18 | 262 | 2.4e-05 | 0.0007494 |
150 | SYSTEM PROCESS | 66 | 1785 | 2.437e-05 | 0.000756 |
151 | REGULATION OF ION TRANSPORT | 30 | 592 | 2.473e-05 | 0.0007621 |
152 | BRANCH ELONGATION OF AN EPITHELIUM | 5 | 17 | 2.589e-05 | 0.0007924 |
153 | POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 19 | 289 | 2.642e-05 | 0.0008035 |
154 | REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL | 8 | 55 | 2.66e-05 | 0.0008036 |
155 | NEURON DEVELOPMENT | 33 | 687 | 2.853e-05 | 0.0008564 |
156 | EMBRYONIC MORPHOGENESIS | 28 | 539 | 2.98e-05 | 0.0008887 |
157 | OUTFLOW TRACT MORPHOGENESIS | 8 | 56 | 3.043e-05 | 0.000902 |
158 | NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS | 58 | 1517 | 3.171e-05 | 0.0009337 |
159 | ANGIOGENESIS | 19 | 293 | 3.191e-05 | 0.0009337 |
160 | REGULATION OF CELL SUBSTRATE ADHESION | 14 | 173 | 3.263e-05 | 0.0009466 |
161 | REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION | 9 | 73 | 3.275e-05 | 0.0009466 |
162 | POSITIVE REGULATION OF GLUCOSE TRANSPORT | 7 | 42 | 3.443e-05 | 0.0009889 |
163 | REGULATION OF HEART CONTRACTION | 16 | 221 | 3.596e-05 | 0.001027 |
164 | CELLULAR RESPONSE TO ACID CHEMICAL | 14 | 175 | 3.706e-05 | 0.00105 |
165 | REGULATION OF TRANSPORTER ACTIVITY | 15 | 198 | 3.725e-05 | 0.00105 |
166 | SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION | 23 | 404 | 3.84e-05 | 0.001076 |
167 | REGULATION OF STEM CELL DIFFERENTIATION | 11 | 113 | 4.256e-05 | 0.001186 |
168 | TAXIS | 25 | 464 | 4.413e-05 | 0.001222 |
169 | CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND | 25 | 465 | 4.57e-05 | 0.001258 |
170 | NEGATIVE REGULATION OF CELL PROLIFERATION | 31 | 643 | 4.662e-05 | 0.001276 |
171 | NEGATIVE REGULATION OF CELL DEVELOPMENT | 19 | 303 | 5.031e-05 | 0.001369 |
172 | REGULATION OF GLUCOSE IMPORT | 8 | 60 | 5.074e-05 | 0.001373 |
173 | LUNG MORPHOGENESIS | 7 | 45 | 5.469e-05 | 0.001463 |
174 | VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT | 7 | 45 | 5.469e-05 | 0.001463 |
175 | MEMBRANE DEPOLARIZATION | 8 | 61 | 5.729e-05 | 0.001523 |
176 | NEGATIVE REGULATION OF CELL DEATH | 38 | 872 | 5.918e-05 | 0.001565 |
177 | POSITIVE REGULATION OF MAP KINASE ACTIVITY | 15 | 207 | 6.205e-05 | 0.001622 |
178 | BONE MORPHOGENESIS | 9 | 79 | 6.177e-05 | 0.001622 |
179 | MEMORY | 10 | 98 | 6.325e-05 | 0.001644 |
180 | REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY | 16 | 232 | 6.441e-05 | 0.001649 |
181 | CARDIAC VENTRICLE MORPHOGENESIS | 8 | 62 | 6.452e-05 | 0.001649 |
182 | POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT | 16 | 232 | 6.441e-05 | 0.001649 |
183 | CARDIAC MUSCLE TISSUE DEVELOPMENT | 12 | 140 | 6.793e-05 | 0.001727 |
184 | REGULATION OF MUSCLE ADAPTATION | 8 | 63 | 7.249e-05 | 0.001833 |
185 | ACTIN FILAMENT BASED PROCESS | 24 | 450 | 7.329e-05 | 0.001843 |
186 | CIRCULATORY SYSTEM PROCESS | 21 | 366 | 7.42e-05 | 0.001847 |
187 | REGULATION OF ACTIN FILAMENT BASED PROCESS | 19 | 312 | 7.438e-05 | 0.001847 |
188 | NEGATIVE REGULATION OF PHOSPHORYLATION | 23 | 422 | 7.463e-05 | 0.001847 |
189 | REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION | 10 | 100 | 7.517e-05 | 0.001851 |
190 | REGULATION OF MEMBRANE POTENTIAL | 20 | 343 | 8.805e-05 | 0.002156 |
191 | RESPONSE TO ACID CHEMICAL | 19 | 319 | 9.966e-05 | 0.002428 |
192 | DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS | 15 | 216 | 0.0001003 | 0.00243 |
193 | PALATE DEVELOPMENT | 9 | 85 | 0.00011 | 0.002637 |
194 | RHO PROTEIN SIGNAL TRANSDUCTION | 7 | 50 | 0.0001095 | 0.002637 |
195 | POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS | 22 | 406 | 0.0001158 | 0.002749 |
196 | EMBRYONIC ORGAN DEVELOPMENT | 22 | 406 | 0.0001158 | 0.002749 |
197 | NEGATIVE REGULATION OF NEURON DEATH | 13 | 171 | 0.0001173 | 0.002771 |
198 | POSITIVE REGULATION OF FAT CELL DIFFERENTIATION | 7 | 51 | 0.0001245 | 0.002896 |
199 | REGULATION OF CELL JUNCTION ASSEMBLY | 8 | 68 | 0.0001256 | 0.002896 |
200 | REPRODUCTIVE SYSTEM DEVELOPMENT | 22 | 408 | 0.0001243 | 0.002896 |
201 | ORGAN GROWTH | 8 | 68 | 0.0001256 | 0.002896 |
202 | POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 41 | 1004 | 0.0001257 | 0.002896 |
203 | NEUROMUSCULAR JUNCTION DEVELOPMENT | 6 | 36 | 0.0001266 | 0.002901 |
204 | POSITIVE REGULATION OF LIPID METABOLIC PROCESS | 11 | 128 | 0.0001325 | 0.003022 |
205 | POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 37 | 876 | 0.0001394 | 0.003163 |
206 | CELLULAR RESPONSE TO PEPTIDE | 17 | 274 | 0.0001408 | 0.003181 |
207 | ESTABLISHMENT OF CELL POLARITY | 9 | 88 | 0.0001439 | 0.003235 |
208 | MUSCLE TISSUE DEVELOPMENT | 17 | 275 | 0.0001471 | 0.003291 |
209 | REGULATION OF TRANSFERASE ACTIVITY | 39 | 946 | 0.0001518 | 0.00338 |
210 | NEURAL PRECURSOR CELL PROLIFERATION | 8 | 70 | 0.0001544 | 0.003405 |
211 | MUSCLE ORGAN MORPHOGENESIS | 8 | 70 | 0.0001544 | 0.003405 |
212 | RESPONSE TO WOUNDING | 27 | 563 | 0.0001563 | 0.00343 |
213 | POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY | 7 | 53 | 0.0001595 | 0.003485 |
214 | SKELETAL SYSTEM MORPHOGENESIS | 14 | 201 | 0.0001644 | 0.003576 |
215 | REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 17 | 278 | 0.0001675 | 0.003608 |
216 | NEURON MIGRATION | 10 | 110 | 0.0001674 | 0.003608 |
217 | POSITIVE REGULATION OF ORGAN GROWTH | 6 | 38 | 0.0001728 | 0.003705 |
218 | CELL FATE COMMITMENT | 15 | 227 | 0.0001737 | 0.003707 |
219 | POSITIVE REGULATION OF VASCULATURE DEVELOPMENT | 11 | 133 | 0.0001861 | 0.003954 |
220 | REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 15 | 229 | 0.0001911 | 0.004006 |
221 | REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 5 | 25 | 0.000192 | 0.004006 |
222 | POSITIVE REGULATION OF DEVELOPMENTAL GROWTH | 12 | 156 | 0.0001907 | 0.004006 |
223 | POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 5 | 25 | 0.000192 | 0.004006 |
224 | REGULATION OF GROWTH | 29 | 633 | 0.0001958 | 0.004067 |
225 | SPECIFICATION OF ORGAN IDENTITY | 4 | 14 | 0.0001993 | 0.004072 |
226 | NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 26 | 541 | 0.0001995 | 0.004072 |
227 | MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL | 4 | 14 | 0.0001993 | 0.004072 |
228 | NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS | 26 | 541 | 0.0001995 | 0.004072 |
229 | REGULATION OF PHOSPHOLIPASE C ACTIVITY | 6 | 39 | 0.0002004 | 0.004072 |
230 | EXOCYTOSIS | 18 | 310 | 0.0002067 | 0.004181 |
231 | POSITIVE REGULATION OF CELL DEATH | 28 | 605 | 0.0002134 | 0.004298 |
232 | REGULATION OF DENDRITIC SPINE DEVELOPMENT | 7 | 56 | 0.0002267 | 0.004548 |
233 | REGULATION OF TRANSMEMBRANE TRANSPORT | 22 | 426 | 0.0002286 | 0.004565 |
234 | CELL CELL ADHESION | 28 | 608 | 0.0002313 | 0.00458 |
235 | REGULATION OF VASCULATURE DEVELOPMENT | 15 | 233 | 0.0002306 | 0.00458 |
236 | CELL PROLIFERATION | 30 | 672 | 0.0002374 | 0.004681 |
237 | CELLULAR RESPONSE TO ALCOHOL | 10 | 115 | 0.0002412 | 0.004719 |
238 | ACTIVATION OF MAPK ACTIVITY | 11 | 137 | 0.0002414 | 0.004719 |
239 | SINGLE ORGANISM CELL ADHESION | 23 | 459 | 0.0002558 | 0.00498 |
240 | REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING | 11 | 138 | 0.0002571 | 0.004985 |
241 | FEMALE SEX DIFFERENTIATION | 10 | 116 | 0.0002589 | 0.004998 |
242 | CYTOSKELETON ORGANIZATION | 35 | 838 | 0.0002606 | 0.00501 |
243 | RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION | 4 | 15 | 0.000267 | 0.005113 |
244 | CHEMICAL HOMEOSTASIS | 36 | 874 | 0.0002774 | 0.005291 |
245 | POSITIVE REGULATION OF HEART GROWTH | 5 | 27 | 0.0002813 | 0.005321 |
246 | REGULATION OF ASTROCYTE DIFFERENTIATION | 5 | 27 | 0.0002813 | 0.005321 |
247 | REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION | 10 | 118 | 0.0002974 | 0.005603 |
248 | REGULATION OF RESPONSE TO STRESS | 53 | 1468 | 0.0002993 | 0.005616 |
249 | NEGATIVE REGULATION OF GTPASE ACTIVITY | 6 | 42 | 0.0003047 | 0.005694 |
250 | SEX DIFFERENTIATION | 16 | 266 | 0.0003109 | 0.005763 |
251 | ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY | 11 | 141 | 0.0003098 | 0.005763 |
252 | RESPONSE TO STEROID HORMONE | 24 | 497 | 0.0003249 | 0.006 |
253 | STEM CELL PROLIFERATION | 7 | 60 | 0.00035 | 0.006386 |
254 | POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION | 7 | 60 | 0.00035 | 0.006386 |
255 | RAS PROTEIN SIGNAL TRANSDUCTION | 11 | 143 | 0.0003498 | 0.006386 |
256 | REGULATION OF JAK STAT CASCADE | 11 | 144 | 0.0003714 | 0.006672 |
257 | RESPONSE TO EXTRACELLULAR STIMULUS | 22 | 441 | 0.0003681 | 0.006672 |
258 | NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION | 11 | 144 | 0.0003714 | 0.006672 |
259 | REGULATION OF STAT CASCADE | 11 | 144 | 0.0003714 | 0.006672 |
260 | REGULATION OF GLUCOSE TRANSPORT | 9 | 100 | 0.0003796 | 0.006793 |
261 | LEUKOCYTE ACTIVATION | 21 | 414 | 0.0003999 | 0.007022 |
262 | APPENDAGE DEVELOPMENT | 12 | 169 | 0.0003987 | 0.007022 |
263 | CARDIAC MUSCLE CELL CONTRACTION | 5 | 29 | 0.000399 | 0.007022 |
264 | LIMB DEVELOPMENT | 12 | 169 | 0.0003987 | 0.007022 |
265 | NEUROBLAST PROLIFERATION | 5 | 29 | 0.000399 | 0.007022 |
266 | CELLULAR RESPONSE TO INSULIN STIMULUS | 11 | 146 | 0.0004178 | 0.007254 |
267 | FOREBRAIN DEVELOPMENT | 19 | 357 | 0.0004165 | 0.007254 |
268 | MULTICELLULAR ORGANISMAL SIGNALING | 10 | 123 | 0.0004152 | 0.007254 |
269 | EMBRYO DEVELOPMENT | 36 | 894 | 0.0004235 | 0.007325 |
270 | REGULATION OF MUSCLE SYSTEM PROCESS | 13 | 195 | 0.0004257 | 0.007337 |
271 | RESPONSE TO EXTERNAL STIMULUS | 62 | 1821 | 0.0004328 | 0.007431 |
272 | INOSITOL LIPID MEDIATED SIGNALING | 10 | 124 | 0.0004429 | 0.007576 |
273 | REGULATION OF ENERGY HOMEOSTASIS | 4 | 17 | 0.0004495 | 0.007605 |
274 | REGULATION OF PROTEIN KINASE A SIGNALING | 4 | 17 | 0.0004495 | 0.007605 |
275 | SMOOTH MUSCLE CONTRACTION | 6 | 45 | 0.0004474 | 0.007605 |
276 | REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY | 5 | 30 | 0.0004702 | 0.007898 |
277 | CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS | 5 | 30 | 0.0004702 | 0.007898 |
278 | REGULATED EXOCYTOSIS | 14 | 224 | 0.0004973 | 0.008323 |
279 | CARDIAC CHAMBER MORPHOGENESIS | 9 | 104 | 0.0005073 | 0.008461 |
280 | REGULATION OF PHOSPHOLIPASE ACTIVITY | 7 | 64 | 0.0005219 | 0.008672 |
281 | REGULATION OF NEURON DEATH | 15 | 252 | 0.0005296 | 0.008769 |
282 | POSITIVE REGULATION OF OSSIFICATION | 8 | 84 | 0.0005448 | 0.00899 |
283 | MACROPHAGE ACTIVATION | 5 | 31 | 0.0005505 | 0.009051 |
284 | NEGATIVE REGULATION OF MOLECULAR FUNCTION | 41 | 1079 | 0.0005529 | 0.009059 |
285 | POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC | 4 | 18 | 0.0005678 | 0.009271 |
286 | REGULATION OF BEHAVIOR | 7 | 65 | 0.0005739 | 0.009336 |
287 | CARDIAC VENTRICLE DEVELOPMENT | 9 | 106 | 0.0005834 | 0.009458 |
288 | EPHRIN RECEPTOR SIGNALING PATHWAY | 8 | 85 | 0.00059 | 0.009532 |
289 | CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION | 19 | 368 | 0.0006027 | 0.009704 |
290 | REGULATION OF REPRODUCTIVE PROCESS | 10 | 129 | 0.0006053 | 0.009713 |
291 | TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER | 11 | 153 | 0.0006206 | 0.009924 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY | 11 | 81 | 1.673e-06 | 0.0005181 |
2 | TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY | 10 | 64 | 1.336e-06 | 0.0005181 |
3 | RAS GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 19 | 228 | 8.519e-07 | 0.0005181 |
4 | CYTOSKELETAL PROTEIN BINDING | 40 | 819 | 2.66e-06 | 0.0006058 |
5 | MOLECULAR FUNCTION REGULATOR | 56 | 1353 | 4.565e-06 | 0.0006058 |
6 | TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING | 22 | 328 | 4.491e-06 | 0.0006058 |
7 | GROWTH FACTOR BINDING | 13 | 123 | 3.493e-06 | 0.0006058 |
8 | ENZYME BINDING | 67 | 1737 | 5.305e-06 | 0.000616 |
9 | NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY | 51 | 1199 | 5.992e-06 | 0.0006185 |
10 | GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 20 | 303 | 1.537e-05 | 0.001428 |
11 | RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING | 31 | 629 | 3.083e-05 | 0.002604 |
12 | TRANSCRIPTION COACTIVATOR BINDING | 4 | 11 | 6.926e-05 | 0.005362 |
13 | MACROMOLECULAR COMPLEX BINDING | 53 | 1399 | 9.072e-05 | 0.006483 |
14 | PROTEIN TYROSINE KINASE ACTIVITY | 13 | 176 | 0.0001566 | 0.009697 |
15 | PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY | 8 | 70 | 0.0001544 | 0.009697 |
16 | SIGNAL TRANSDUCER ACTIVITY | 61 | 1731 | 0.0001959 | 0.0099 |
17 | CYTOKINE BINDING | 9 | 92 | 0.0002025 | 0.0099 |
18 | ACTIN BINDING | 21 | 393 | 0.0001994 | 0.0099 |
19 | HEPARIN BINDING | 12 | 157 | 0.0002025 | 0.0099 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | SYNAPSE | 52 | 754 | 3.655e-13 | 2.135e-10 |
2 | EXCITATORY SYNAPSE | 24 | 197 | 1.349e-11 | 3.938e-09 |
3 | POSTSYNAPSE | 31 | 378 | 4.285e-10 | 4.386e-08 |
4 | NEURON PROJECTION | 53 | 942 | 4.506e-10 | 4.386e-08 |
5 | CELL PROJECTION | 81 | 1786 | 3.371e-10 | 4.386e-08 |
6 | SYNAPSE PART | 41 | 610 | 2.943e-10 | 4.386e-08 |
7 | NEURON PART | 61 | 1265 | 7.84e-09 | 6.541e-07 |
8 | SOMATODENDRITIC COMPARTMENT | 38 | 650 | 5.804e-08 | 4.237e-06 |
9 | MEMBRANE REGION | 50 | 1134 | 2.758e-06 | 0.000179 |
10 | PLASMA MEMBRANE REGION | 41 | 929 | 2.248e-05 | 0.001313 |
11 | DENDRITE | 25 | 451 | 2.772e-05 | 0.001472 |
12 | FILOPODIUM | 10 | 94 | 4.417e-05 | 0.002057 |
13 | CYTOSKELETON | 70 | 1967 | 4.578e-05 | 0.002057 |
14 | ACTIN BASED CELL PROJECTION | 14 | 181 | 5.366e-05 | 0.002238 |
15 | CELL JUNCTION | 46 | 1151 | 8.013e-05 | 0.002942 |
16 | CYTOPLASMIC VESICLE PART | 29 | 601 | 8.06e-05 | 0.002942 |
17 | CATION CHANNEL COMPLEX | 13 | 167 | 9.232e-05 | 0.003172 |
18 | NEURONAL POSTSYNAPTIC DENSITY | 7 | 53 | 0.0001595 | 0.004904 |
19 | CELL PROJECTION PART | 39 | 946 | 0.0001518 | 0.004904 |
20 | PRESYNAPSE | 17 | 283 | 0.0002069 | 0.006042 |
21 | VOLTAGE GATED CALCIUM CHANNEL COMPLEX | 6 | 40 | 0.0002314 | 0.006436 |
22 | TRANSPORTER COMPLEX | 18 | 321 | 0.0003157 | 0.00838 |
Num | Pathway | Pathview | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|---|
1 | hsa04510_Focal_adhesion | 16 | 200 | 1.046e-05 | 0.001884 | |
2 | hsa04014_Ras_signaling_pathway | 15 | 236 | 0.0002647 | 0.02027 | |
3 | hsa04010_MAPK_signaling_pathway | 16 | 268 | 0.0003379 | 0.02027 | |
4 | hsa04350_TGF.beta_signaling_pathway | 8 | 85 | 0.00059 | 0.02359 | |
5 | hsa04390_Hippo_signaling_pathway | 11 | 154 | 0.0006554 | 0.02359 | |
6 | hsa04720_Long.term_potentiation | 7 | 70 | 0.000899 | 0.02697 | |
7 | hsa04270_Vascular_smooth_muscle_contraction | 9 | 116 | 0.001116 | 0.0287 | |
8 | hsa04310_Wnt_signaling_pathway | 10 | 151 | 0.002009 | 0.0452 | |
9 | hsa04360_Axon_guidance | 9 | 130 | 0.002461 | 0.04562 | |
10 | hsa02010_ABC_transporters | 5 | 44 | 0.00278 | 0.04562 | |
11 | hsa04512_ECM.receptor_interaction | 7 | 85 | 0.00279 | 0.04562 | |
12 | hsa04810_Regulation_of_actin_cytoskeleton | 12 | 214 | 0.003042 | 0.04562 | |
13 | hsa04151_PI3K_AKT_signaling_pathway | 16 | 351 | 0.005382 | 0.07158 | |
14 | hsa04520_Adherens_junction | 6 | 73 | 0.005568 | 0.07158 | |
15 | hsa04340_Hedgehog_signaling_pathway | 5 | 56 | 0.007882 | 0.09458 | |
16 | hsa04514_Cell_adhesion_molecules_.CAMs. | 8 | 136 | 0.01093 | 0.123 | |
17 | hsa04910_Insulin_signaling_pathway | 8 | 138 | 0.01187 | 0.1257 | |
18 | hsa04630_Jak.STAT_signaling_pathway | 8 | 155 | 0.02235 | 0.2235 | |
19 | hsa04916_Melanogenesis | 6 | 101 | 0.02485 | 0.2355 | |
20 | hsa04260_Cardiac_muscle_contraction | 5 | 77 | 0.02806 | 0.2525 | |
21 | hsa04974_Protein_digestion_and_absorption | 5 | 81 | 0.0339 | 0.2906 | |
22 | hsa04144_Endocytosis | 9 | 203 | 0.03749 | 0.3067 | |
23 | hsa04020_Calcium_signaling_pathway | 8 | 177 | 0.04387 | 0.3433 | |
24 | hsa00670_One_carbon_pool_by_folate | 2 | 18 | 0.05929 | 0.4447 | |
25 | hsa00531_Glycosaminoglycan_degradation | 2 | 19 | 0.06532 | 0.4624 | |
26 | hsa04115_p53_signaling_pathway | 4 | 69 | 0.06679 | 0.4624 | |
27 | hsa04971_Gastric_acid_secretion | 4 | 74 | 0.08175 | 0.545 | |
28 | hsa00510_N.Glycan_biosynthesis | 3 | 49 | 0.09436 | 0.6066 | |
29 | hsa00760_Nicotinate_and_nicotinamide_metabolism | 2 | 24 | 0.09817 | 0.6093 | |
30 | hsa04062_Chemokine_signaling_pathway | 7 | 189 | 0.1277 | 0.766 | |
31 | hsa00230_Purine_metabolism | 6 | 162 | 0.1513 | 0.8785 | |
32 | hsa04666_Fc_gamma_R.mediated_phagocytosis | 4 | 95 | 0.1598 | 0.899 | |
33 | hsa04972_Pancreatic_secretion | 4 | 101 | 0.1859 | 1 | |
34 | hsa04920_Adipocytokine_signaling_pathway | 3 | 68 | 0.1911 | 1 | |
35 | hsa04730_Long.term_depression | 3 | 70 | 0.2024 | 1 | |
36 | hsa04976_Bile_secretion | 3 | 71 | 0.2081 | 1 | |
37 | hsa04960_Aldosterone.regulated_sodium_reabsorption | 2 | 42 | 0.2383 | 1 | |
38 | hsa04146_Peroxisome | 3 | 79 | 0.2551 | 1 | |
39 | hsa04670_Leukocyte_transendothelial_migration | 4 | 117 | 0.2609 | 1 | |
40 | hsa04330_Notch_signaling_pathway | 2 | 47 | 0.2795 | 1 | |
41 | hsa04110_Cell_cycle | 4 | 128 | 0.3153 | 1 | |
42 | hsa04970_Salivary_secretion | 3 | 89 | 0.3154 | 1 | |
43 | hsa04150_mTOR_signaling_pathway | 2 | 52 | 0.3206 | 1 | |
44 | hsa04540_Gap_junction | 3 | 90 | 0.3215 | 1 | |
45 | hsa00500_Starch_and_sucrose_metabolism | 2 | 54 | 0.3368 | 1 | |
46 | hsa04530_Tight_junction | 4 | 133 | 0.3405 | 1 | |
47 | hsa00562_Inositol_phosphate_metabolism | 2 | 57 | 0.361 | 1 | |
48 | hsa04912_GnRH_signaling_pathway | 3 | 101 | 0.3881 | 1 | |
49 | hsa04114_Oocyte_meiosis | 3 | 114 | 0.4645 | 1 | |
50 | hsa04142_Lysosome | 3 | 121 | 0.5039 | 1 | |
51 | hsa04070_Phosphatidylinositol_signaling_system | 2 | 78 | 0.5182 | 1 | |
52 | hsa04664_Fc_epsilon_RI_signaling_pathway | 2 | 79 | 0.5251 | 1 | |
53 | hsa04722_Neurotrophin_signaling_pathway | 3 | 127 | 0.5364 | 1 | |
54 | hsa04914_Progesterone.mediated_oocyte_maturation | 2 | 87 | 0.5774 | 1 | |
55 | hsa04640_Hematopoietic_cell_lineage | 2 | 88 | 0.5836 | 1 | |
56 | hsa04210_Apoptosis | 2 | 89 | 0.5898 | 1 | |
57 | hsa04120_Ubiquitin_mediated_proteolysis | 3 | 139 | 0.5977 | 1 | |
58 | hsa04660_T_cell_receptor_signaling_pathway | 2 | 108 | 0.6941 | 1 | |
59 | hsa04141_Protein_processing_in_endoplasmic_reticulum | 3 | 168 | 0.7226 | 1 | |
60 | hsa04380_Osteoclast_differentiation | 2 | 128 | 0.7792 | 1 | |
61 | hsa04740_Olfactory_transduction | 2 | 388 | 0.9985 | 1 |